EGFR-IN-212 is an EGFR inhibitor with human IC50 values of 1.83 µM. EGFR-IN-212 reduces EGFR mRNA expression and induces apoptosis. EGFR-IN-212 can be used for the research of non-small cell lung carcinoma[1].
Molecular Weight:
391.53
Formula:
C22H25N5S
Target:
Apoptosis,EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
